- Published at
- by investing.com
positive
positive
Serina Therapeutics director buys $88.2k in company stock By Investing.com
Serina Therapeutics director buys $88.2k in company stock
News for AgeX Therapeutics, Inc. (AGE)
- Published at
- by globenewswire.com
mixedmixedSerina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its...- Published at
- by marketscreener.com
mixedmixed- Published at
- by globenewswire.com
mixedmixedSerina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical...- Published at
- by globenewswire.com
positivepositiveAgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX -February 27, 2024 at 08:53 pm EST
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...- Published at
- by benzinga.com
mixedmixedWhy IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Acutus Medical (NASDAQ:AFIB), AgeX Therapeutics (AMEX:AGE)
Shares of International Business Machines Corporation (NYSE: IBM) shares rose sharply in today’s pre-market trading as the company reported reported stronger-than-expected results for its fourth quarter.- Published at
- by rttnews.com
positivepositiveAgeX Therapeutics Continues To Slide
AgeX Therapeutics, Inc. (AGE) shares are declining more than 33 percent on Friday morning trade, continuing a bearish trend. There have been no stock-impacting news so far today.- Published at
- by globenewswire.com
positivepositiveSerina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer
Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023 (GLOBE...- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPT, NXGN, AGE, SMMF
NEW YORK, Oct. 28, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN -September 18, 2023 at 11:43 pm EDT
NEW YORK, Sept. 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...- Published at
- by globenewswire.com
positivepositiveBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasd
BALA CYNWYD, Pa., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...- Published at
- by prnewswire.com
mixedmixed- Published at
- by markets.businessinsider.com
mixedmixed- Published at
- by markets.businessinsider.com
mixedmixed58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the ful...ZKINXYFVYNTVYGRTMCITBASKLZ.MXSKLZ-WTSKLZSJOYWSJRVPHWRVPHQUREPHXPFPT.MXPFPTOCGNNWGIWNEWNAKDMVISMVIN.DEMICTLMNLLABPKXINITIIRIXINTZINMIN.TOIDNGSXN.MXGSXGRAFTFTELYS.NEELYSDNMR.MXDNMRCSPRCCIVCASIBWAY.TABRSYFBOXLBNGOWBNGO.MXBNGOBIVIAMPGWAMPGALGSAEZS.TOAEZSACYVYGR.MXLAZR.MXLAZRCCIV.MXCCIV-WTCCIV-UNAXSMAGEACRX- Published at
- by prnewswire.com
mixedmixedGlobal Mesenchymal Stem Cells (MSC) Market Report 2021-2027: Market Competitors areExploring Commercialization Strategies for MSC-Derived Extracellular Vesicles (EVs) and Exosomes
/PRNewswire/ -- The- Published at
- by thestreet.com
mixedmixedGlobal Mesenchymal Stem Cells (MSC) Market Report 2021-2027: Market Competitors AreExploring Commercialization Strategies For MSC-Derived Extracellular Vesicles (EVs) And Exosomes
DUBLIN, Feb. 15, 2021 /PRNewswire/ -- The